|
|
 |
|
Viewing report
|
|
|
|
Indias Growth Prospects in Pharma: Evolution, Not Revolution
Datamonitor, Dec 2005, Pages: 193
The value of the Indian pharmaceutical industry grew 11% in 2004 from 2003; with the top 10 Indian pharmas accounting for 46% of the market, and R&D spend increasing by 36%. Compliance with international intellectual property protection and an increasing threat of foreign players moving into India are factors currently changing the dynamics of the market.
Scope of this title:
- Overview of the Indian healthcare system including recent legislative changes on patent laws, compulsory licensing and tax incentives
- Examines the evolution of the Indian pharmaceutical industry and the performance of the 10 leading domestic players
- Assessment of the strength of Indias offering in generics, contract services and innovation for domestic development and geographic expansion
- Strategic evaluation of the leading growth strategies available for Indian players and foreign companies
Highlights of this title:
Indian companies have recognized the opportunity presented by western pharma in search of lower costs and higher profits, and are exploiting the low cost base and pool of highly skilled labor in their market to develop a thriving outsourcing industry, positioning India as a key provider of contract research and manufacturing services.
India is increasing its R&D and biotechnology focus and taking advantage of the low R&D productivity of developed markets to gain partnerships with western players. These alliances enable the companies to gain expertise in discovery and development as well as maximizing revenues if and when products reach the market.
Pharmas and biotechs in the US, Europe and Japan have realized the increasing role of India at a global level. Many players are outsourcing non-core activities of the research and manufacturing process. Outsourcing is a popular option, while off-shoring via direct investment, joint venture or acquisition is also proving successful.
Reasons to order your copy:
- Understand the dynamics of the Indian pharma sector and the effect of recent changes in patent laws and tax policies on the evolution of the market
- Assess the different strategic options available for Indian companies to succeed through domestic and international expansion
- Identify outsourcing and off-shoring opportunities for foreign players to leverage Indias cost advantages, intellectual capital and novel R&D
Customers who bought this item also bought
The Indian Pharmaceutical Market to 2011: Competitive Dynamics and Major Players
The Indian Pharmaceutical Industry 2009: Diversification, Expansion & Ambitions
The Indian Pharmaceutical Market Outlook To 2014: Market Trends, Key Players, Forecast
The Top 10 Pharmaceutical Companies in India: Growth Strategies, Performance and SWOT Analyses
Indian Pharmaceutical Industry: Issues and Opportunities
Innovative Strategies and Models for R&D Success: The Evolving Networked Pharma Company
Kick-Starting R&D in India: Challenges and Opportunities
Pharmaceutical Outsourcing in Drug Discovery and Development: Contract Research Opportunity in India
State of the Pharmaceutical Industry, 2010 - Critical Role of Midsize Pharma
SPECIAL REPORT: Lessons Learned in the Pharma Industry, 2008
Indian Pharmaceutical Industry: Strategies, Trends and Opportunities
BRIC Diabetes Drugs Market
|
|
|
|
